Delivery Order SPE2DB22D3301-SPE2DB25FY4TS

Award Date 5/13/25
Potential Completion Date 6/4/25
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ENVARSUS XR 1 MG TABLET 30S. The contract has a ceiling value of $2,168.68 and a period of performance through July 2, 2025. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price of $1,718.48 and a completion date of June 11, 2025. The contract is not set aside and was awarded on May 20, 2025. Amerisourcebergen Drug Corp is the prime contractor and this award is...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,718.48, is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of April 1, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,148.10, is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a performance period ending on January 30, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,711.95 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ENVARSUS XR 4 MG TABLET 100S. The contract has a completion date of July 1, 2025 and is not a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,577.72 firm fixed-price delivery order is for the supply of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,718.48 firm fixed-price delivery order is for the supply of ENVARSUS XR 1 MG TABLET 100S, a specialty medication. The contract has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a $1,718.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product, with a period of performance through May 5, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,711.95 firm fixed-price delivery order is for the supply of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a $1,711.95 firm fixed-price delivery order for the medication ENVARSUS XR 4 MG TABLET 100S. The contract has an ultimate completion date of June 20, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY4TS
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENVARSUS XR 4 MG TABLET 100S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $5,135.85 and a period of performance through June 4, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/12/25, 12:05 PM